Metabolism of di (2-ethylhexyl) phthalate (DEHP): comparative study in juvenile and fetal marmosets and rats
- PMID: 22293410
- DOI: 10.2131/jts.37.33
Metabolism of di (2-ethylhexyl) phthalate (DEHP): comparative study in juvenile and fetal marmosets and rats
Abstract
We compared the metabolic profile of di (2-ethylhexyl) phthalate (DEHP) in juveniles and fetus between rats and marmosets. STUDY-I: (14)C-DEHP (100 and 2,500 mg/kg) was singly administered to juvenile and adult marmosets by gavage. C(max) of the radioactivity in juvenile marmosets was 6.45 and 31 µg eq./g, respectively. The radioactivity excreted mainly into feces; however, at least 10% of the radioactivity was absorbed even at 2,500 mg/kg. No abnormal accumulation was observed in the male reproductive organs. STUDY-II: (14)C-DEHP (100 mg/kg) was singly administered to juveniles of rat and marmoset. The plasma radioactivity in marmosets was about 5% to 9% of that in rats. Free forms of mono-2-ethylhexyl phthalate (MEHP) and its oxidized metabolites such as oxo-, OH-, and COOH-MEHP were detected as the main compositions in rat plasma. In marmosets, free form of MEHP was also detected as a major composition, but not for oxidized MEHP metabolites. In rats, oxidized MEHP metabolites were excreted into urine as unconjugated forms. MEHP and its oxidized metabolites were also detected in marmoset urine; however, they were mostly glucuronized. No specific accumulation of the radioactivity was noted in the testes of either species; however, the radioactivity concentration in the marmoset testes was much lower than that in rats. STUDY-III: (14)C-DEHP (100 mg/kg) was singly administered to dams on gestation day 130 for marmosets and day 20 for rats. In either species, no specific accumulation of radioactivity was noted in the testis of fetuses from the dams treated with (14)C-DEHP; however, the radioactivity in the rat testis was about 20-times higher than that in the marmoset. Major metabolite components in rat whole fetal tissue were free forms of MEHP, OH-MEHP, and oxo-MEHP. Free form of MEHP was also detected as only a peak in the marmoset fetal tissue.
Similar articles
-
Blood burden of di(2-ethylhexyl) phthalate and its primary metabolite mono(2-ethylhexyl) phthalate in pregnant and nonpregnant rats and marmosets.Toxicol Appl Pharmacol. 2004 Mar 1;195(2):142-53. doi: 10.1016/j.taap.2003.11.014. Toxicol Appl Pharmacol. 2004. PMID: 14998681
-
New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP.Arch Toxicol. 2005 Jul;79(7):367-76. doi: 10.1007/s00204-004-0642-4. Epub 2005 Feb 8. Arch Toxicol. 2005. PMID: 15700144
-
Effect of in utero exposure to di-(2-ethylhexyl)phthalate: distribution in the rat fetus and testosterone production by rat fetal testis in culture.Food Chem Toxicol. 2006 Dec;44(12):2064-9. doi: 10.1016/j.fct.2006.07.007. Epub 2006 Aug 8. Food Chem Toxicol. 2006. PMID: 16979278
-
Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure-- an update and latest results.Int J Androl. 2006 Feb;29(1):155-65; discussion 181-5. doi: 10.1111/j.1365-2605.2005.00607.x. Int J Androl. 2006. PMID: 16466535 Review.
-
Toxicity and metabolism of monoethylhexyl phthalate and diethylhexyl phthalate: a survey of recent literature.J Toxicol Environ Health. 1982 Jan;9(1):141-52. doi: 10.1080/15287398209530149. J Toxicol Environ Health. 1982. PMID: 7038132 Review.
Cited by
-
Refinement and calibration of a human PBPK model for the plasticiser, Di-(2-propylheptyl) phthalate (DPHP) using in silico, in vitro and human biomonitoring data.Front Pharmacol. 2023 Feb 2;14:1111433. doi: 10.3389/fphar.2023.1111433. eCollection 2023. Front Pharmacol. 2023. PMID: 36865923 Free PMC article.
-
Rapidity and Precision of Steroid Hormone Measurement.J Clin Med. 2022 Feb 12;11(4):956. doi: 10.3390/jcm11040956. J Clin Med. 2022. PMID: 35207229 Free PMC article. Review.
-
Development, Testing, Parameterisation and Calibration of a Human PBPK Model for the Plasticiser, Di-(2-propylheptyl) Phthalate (DPHP) Using in Silico, in vitro and Human Biomonitoring Data.Front Pharmacol. 2021 Sep 2;12:692442. doi: 10.3389/fphar.2021.692442. eCollection 2021. Front Pharmacol. 2021. PMID: 34539393 Free PMC article.
-
Update of the risk assessment of di-butylphthalate (DBP), butyl-benzyl-phthalate (BBP), bis(2-ethylhexyl)phthalate (DEHP), di-isononylphthalate (DINP) and di-isodecylphthalate (DIDP) for use in food contact materials.EFSA J. 2019 Dec 11;17(12):e05838. doi: 10.2903/j.efsa.2019.5838. eCollection 2019 Dec. EFSA J. 2019. PMID: 32626195 Free PMC article.
-
Application of a combined aggregate exposure pathway and adverse outcome pathway (AEP-AOP) approach to inform a cumulative risk assessment: A case study with phthalates.Toxicol In Vitro. 2020 Aug;66:104855. doi: 10.1016/j.tiv.2020.104855. Epub 2020 Apr 8. Toxicol In Vitro. 2020. PMID: 32278033 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
